移植肾动脉狭窄血管内介入治疗后的远期移植物及患者生存:单中心经验
该单中心回顾性研究分析了2017年3月至2024年7月因疑似移植肾动脉狭窄行二氧化碳血管造影的肾移植患者。19例患者共接受23次血管内手术,占同期移植患者的1.7%。介入后收缩期峰值流速和肌酐均显著下降,6个月透析脱离率75%,5年随访时6个移植肾仍有功能且患者生存率100%。
要点
- 二氧化碳血管造影联合球囊扩张/支架可有效治疗移植肾动脉狭窄。
- 介入后吻合口收缩期峰值流速和肌酐显著下降,移植肾功能改善。
- 远期移植物和患者生存率高,第一年后无需再次干预。
核心结论
- 与快速进展性移植物功能不全相关的吻合口旁移植肾动脉狭窄可通过二氧化碳血管造影和球囊扩张/支架成功挽救,成功率高。
- 该治疗可带来较高的远期移植物和患者生存率。
研究设计与样本
- 回顾性单中心研究,纳入2017年3月至2024年7月因疑似移植肾动脉狭窄行二氧化碳血管造影的肾移植患者。
- 共识别19例患者接受23次血管内手术,占同期移植患者的1.7%;3例仅行诊断性造影未干预被排除,最终分析16例患者(56%男性),平均年龄52岁。
- 移植至移植肾动脉狭窄干预的平均时间为196天(范围55-726天)。
- 统计方法采用Wilcoxon符号秩检验。
主要发现
- 吻合口收缩期峰值流速介入前平均426 cm/s(SD=235),介入后平均263 cm/s(SD=124),P=0.015。
- 基于多普勒超声,16例中12例移植肾动脉狭窄 resolved or improved。
- 血肌酐从介入前平均3.2(SD=1.4)降至介入后1.6(SD=0.5),P<0.001。
- 14例(75%)患者在移植肾动脉狭窄干预后6个月免于透析。
- 5年随访时6个移植肾仍有功能,且1年时仍功能的移植肾在5年时100%仍有功能,第一年后无移植肾动脉狭窄再干预;患者生存率100%。
关键数值与推荐
- 移植肾动脉狭窄诊断基于多普勒超声和不明原因移植物功能不全,且排除输尿管梗阻、感染或急性排斥反应。
- 球囊扩张所用球囊中位尺寸为3.5 mm(范围2.5-5 mm)。
- 评估指标包括介入前后肌酐、多普勒超声流速以及6个月、1年、5年免于透析率。
临床怎么用
- 对于移植肾动脉狭窄伴快速进展性移植物功能不全的患者,可考虑采用二氧化碳血管造影联合球囊扩张/支架进行挽救性治疗。
- 介入后应通过多普勒超声和肌酐监测评估疗效,长期随访关注移植物功能和患者生存。
局限性
- 回顾性单中心研究,样本量小(最终分析16例患者)。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transplant renal artery stenosis (TRAS) is a recognized etiology of allograft dysfunction and potential graft loss. Endovascular therapy via carbon dioxide angiography (CO2A) and angioplasty/stenting represents an opportunity to mitigate allograft failure in transplant patients with progressive TRAS. We present our institutional experience with CO2A and endovascular interventions in treating TRAS. METHODS: A retrospective review was performed of all renal transplant patients who underwent CO2A for suspected TRAS between March 2017 and July 2024. The diagnosis of TRAS was based on duplex ultrasound (DUS) and unexplained graft dysfunction in the absence of ureteral obstruction, infection, or acute rejection. Pre and postintervention creatinine (Cr), DUS velocities, and freedom from dialysis at 6 months, 1 year, and 5 years were examined. Statistical analysis was performed using Wilcoxon signed-rank test. RESULTS: 19 patients were identified who underwent 23 endovascular procedures for transplant renal artery stenosis, comprising 1.7% of all transplant patients in that time frame. 3 patients underwent diagnostic CO2A without intervention and were excluded from analysis. The remaining 16 patients (56% male) had a mean age of 52 years. Time from transplant to TRAS intervention averaged 196 days (range 55-726). Anastomotic peak systolic velocity (PSV)pre and postintervention averaged 426 cm/s (SD = 235) and 263 cm/s (SD = 124), (P = 0.015), respectively. TRAS was resolved or improved based on DUS in 12 of 16 patients; the median balloon size used for angioplasty was 3.5 mm (range 2.5-5 mm). Preto postintervention Cr decreased from mean 3.2 (SD = 1.4) to 1.6 (SD = 0.5) (P < 0.001). 14 (75%) patients were free from dialysis at 6 months from TRAS intervention. At the 5-year follow-up period, 6 transplanted kidneys were still functioning, and 100% of those functioning at 1 year were still functioning at 5 years, with no TRAS reintervention after the first year. In our cohort, patient survival was 100%. CONCLUSION: Juxta-anastomotic TRAS associated with rapidly progressive allograft dysfunction can be successfully salvaged with a high rate of success with CO2A and angioplasty/stenting. This can lead to high rates of long-term allograft and patient survival.
引用
- Hegazi M, Kabutey NK, Redfield RR, et al. Long-Term Graft and Patient Survival Following Endovascular Intervention for Renal Artery Stenosis in Transplanted Kidneys: A Single-Center Experience. Ann Vasc Surg. 2026. PMID: 42349640. doi:10.1016/j.avsg.2026.05.117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。